Pierre Fabre: Time to Reap R&D Rewards In-House
Executive Summary
Recent Big Pharma deals validate Pierre Fabre's productive research, and underline mid-sized pharmas' importance as a product source. But the French group hasn't yet fully capitalized on its R&D.